Carcinoma Intraductal da Mama
Abstract
The author deals with the intraductal
carcinoma (ductal carcinoma in situ)
with special reference to the
histological aspects as well as the
various forms of treatment instituted.
Among the intraductal carcinomas the
comedocarcinoma in situ is the one
that presents the worse prognosis.
Among the factors that contribut to the
greater agressivitų of this histologic
subtype are the greater chance to be
associated with the occult invasion
and multicentricity, the elevated index
of aneuploidia, the superexpression of
the protein neu of the encogene HER-2/
neu.
The author describes in detail the
various subtypes of intraductal carcinoma including the comedocarcinoma
in situ, the carcinoma micropapillar,
carcinoma cribiformis, apocrine carcinoma, clinging carcinoma, clear cellcar- cinoma, solid carcinoma, clinging carcinoma "signet-ring type" cystic
hypersecretory carcinoma.
Downloads
References
1. Ashton, MA e Norris, HJ, Breast
chapter 12. In: Pathology of Incipient
Neoplasia. Henseon, DE e AlboresSaavedra, J (eds). Saunders, Filadelfia,
1993
2. Ashikari, R, Hajda, Sl.e Robbins,
Gf. Intracdutal carcinoma of the breast
(1960-1969) Câncer, 28:1182, 1971
3. Azzopardi, JG. Problems in Breast
Pathology. Major Problems in Pathology,
VI 11. Saunders, Filadelfia, 1979
4. Bloodgood, JC. Borderline Breast
Tumors, Ann Surg, 93:235, 1931
5. Bloodgood, JC. Comedocarcinoma
(or comedoadenoma) of femele breast.
Am. J. Câncer, 22:842, 1934
6. Broders, AC. Carcinoma in situ
contrasted with penetrating epithelium,
JAMA 99;1670, 1932
7. Carter, D e Smith, RL. Carcinoma
in situ of. the breast. Cancer, 52:14,
1983
8. Cheatle, GL. Early recognition of
cancer of breast. Br. Med. J1:1205,
1906.9. De Potter, CR, Praet, MM, Slavin,
RE et al. Feulgen DNA content and
mitotic activity in proliferative breast
disease. A comparion with ductal carcinoma in situ. Histopathology, 11:1307,
1987
10. Dervan, PA, Gilmartin, LG, Loftus,
BM,e Carney, DN. Breast carcinoma
Kinetics. Argyrophilic nucleolar
organizer regions counts correlate with
ki 67 scores. Am. J. Clin. Pathol., 92:401,
1989
11. Fischer, ER. The impact of
pathology in Biologic, Diagnostic
Prognostic and Therapeutic
Considerations in breast cancer. Surg
Clin North Amer, 64:1073, 1984
12. Fischer, ER, Saas, R, Fischer, Bet
al.Pathologic findings from the Nat.
Surgical Adjuvant Project (Protocol 6). IIntraductal carcinoma. (DCIS), Cancer 57:197, 1966
13. frykberg, ER, Bland, KIe
Copeland, EM. The detection and
treatment of early breast cancer. In:
Advances in Surgery, vol. 23. Tompkins,
RK (editor). Year Book Medical
Publishers. Chicago, 1990.14. Gump, FE, Shikora, S, Habif, DV
et al. The extent and distribution of
cancer in breast with palpable tumors.
Ann Surg, 204:384, 1986
15. Harris, JR. Clinical Management
of ductal Carcinoma in situ. In:Breast
Disease. Harris, JR, Hellman.
Henderson, IC e Kinne. DW (eds)
Lippincott, New York, 1991
16. Kallioliemi, OP, Blanc, G,
Alavaikko, Met al. Tumor DNA ploidy as
an independent proghnostic factor in
breast câncer. Br. Ca.,56:637, 1987
17. lagios, MD, Westdhal, PR,
Margolin, et al. Duct Carcinoma in situ.
Relationship of extent of noninsive
disease to the frequency of occult
invasion, multicentricity, lymph node
metastases and short-term treament
failures. Câncer 50:1309, 1982
18. Lagios, MD Carcinoma ductal in
situ. Patologia e Tratamento. In: Câncer da Mama em 1990, vl. I Cady, BN
e Bland, Kl (eds). Clin Cirurg Amer
Norte. Interlivros, 1990.
19. lewis, De Geschickter, CF.
Comedocarcinoma of the breast. Arch.
Surg. ,36:225, 1938
20. Rosen, PP, Senie, R.
Schottenfled, D et al. Noninvasive
breast carcinoma. frequency of
unsuspected invasion and implications
for treatment. Ann. Surg, 189:377, 1979
21. Rosen O. Lobular carcinoma in
situ and intraductal carcinoma of the
breast. Monogr Pathol, 25:59, 1984
22. Rosen, PP e Scott, M. Custic
Hupersecretory duct carcinoma of the
breast Amer. J Surg Pathol, 8:31, 1984
23. Schnitt, SJ. Pathology of in situ
carcinoma. In: Breast Diseases. Harris,
JR, Hellman, S Henderson, IC e Kine,
DW. (eds). llppincott, New York, 1991
24. Shap, JP, Rosen, PP, Robbins,
Gf. Pitfalls of local excision in the
treatment of carcinoma of the breast.
Sug. Gynecol obstet, 136:721, 1973.
25. Silvertein, MJ, Rosser, R.
Gienson, Eet al. Intraductal Breast carcinoma (DCIS). A therapeutic dilemma.
Proc. Soc. Clin Oncol, 7:25, 1988
26. Sunshine, JB, Moseley, HS,
Fletcher, WS et al. Breast carcinoma in
situ. A retrospective review of 112
cases with a minimum 10 year followup. Am. J. Surg, 150:44, 1985
27. Tarter, Pl Management of nomplapable breast cancer:Treatment options. In Nonplalpable Breast Cancer.Herman, G, Schwartz, IS e Tarter,
(eds), Igaku-Shoin, N. York, 1992
PI,
28. Travassoli, FA. Pathology of the
Breast. Elsevier, New York. 1992
29. Tinnemans, JGM, Webber, T,
Van der Sluis, Rf et al. Multicentricity in
non-palpable breast carcinoma and its
implicatin for treatment. Am. J. Surg,
151:334, 1986
30. Tuluson, AB, Romay, G, Egger, Н
et al. A contribution to the natural
history of breast cancer. V. Bilateral
primary breast cancer:incidence, risks
and diagnosis of simultaneous primary
cancer in the oposite breast. ArchGynecol 237:85, 1985
31. Von Reuden DG, Wilson, RE.
Intraductal carcinoma of the breast.
Surg. Guneco Obstet, 158:105, 1984
32. Westbrook, KC, Gallager, HS.
Intraductal carcinoma of breast. A
comparative studų. Am. J. Surg, m
85:791, 1962
33. Webber, BL, Heise, N, Neifelt, JP
et al. Risk of subsequent contralateral
breast carcinoma in a populatin of
patiens with in situ carcinoma, Cancer,
47:2928 1981.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ely Chaves
This work is licensed under a Creative Commons Attribution 4.0 International License.
